Literature DB >> 24889768

Gastric cancer drug trials - are women second class citizens?

Manish A Shah1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24889768     DOI： 10.1038/nrclinonc.2013.231-c2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

Review 1.  A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion.

Authors:  Alessio Farcomeni
Journal:  Stat Methods Med Res       Date:  2007-08-14       Impact factor: 3.021

2.  Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era.

Authors:  Manish A Shah
Journal:  Nat Rev Clin Oncol       Date:  2013-12-03       Impact factor: 66.675

3.  Gastric cancer drug trials - are women second class citizens?

Authors:  Lishi Wang; Yan Jiao; Yun Jiao; Yanhong Cao; Weikuan Gu
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

4.  Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.

Authors:  Atsushi Ohtsu; Manish A Shah; Eric Van Cutsem; Sun Young Rha; Akira Sawaki; Sook Ryun Park; Ho Yeong Lim; Yasuhide Yamada; Jian Wu; Bernd Langer; Michal Starnawski; Yoon-Koo Kang
Journal:  J Clin Oncol       Date:  2011-08-15       Impact factor: 44.544

5.  Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Authors:  Charles S Fuchs; Jiri Tomasek; Cho Jae Yong; Filip Dumitru; Rodolfo Passalacqua; Chanchal Goswami; Howard Safran; Lucas Vieira Dos Santos; Giuseppe Aprile; David R Ferry; Bohuslav Melichar; Mustapha Tehfe; Eldar Topuzov; John Raymond Zalcberg; Ian Chau; William Campbell; Choondal Sivanandan; Joanna Pikiel; Minori Koshiji; Yanzhi Hsu; Astra M Liepa; Ling Gao; Jonathan D Schwartz; Josep Tabernero
Journal:  Lancet       Date:  2013-10-03       Impact factor: 79.321

6.  Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.

Authors:  Eric Van Cutsem; Sanne de Haas; Yoon-Koo Kang; Atsushi Ohtsu; Niall C Tebbutt; Jian Ming Xu; Wei Peng Yong; Bernd Langer; Paul Delmar; Stefan J Scherer; Manish A Shah
Journal:  J Clin Oncol       Date:  2012-05-07       Impact factor: 44.544

7.  Multiple hypotheses testing procedures in clinical trials and genomic studies.

Authors:  Qing Pan
Journal:  Front Public Health       Date:  2013-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.